Letter to the Editor: Placebo drift, dose heterogeneity, and the winner’s curse—Re-evaluating the hierarchy of MASH therapeutics

Hepatology 2026

View at publisher

Authors: Cyriac Abby Philips, Tharun Tom Oommen, Rizwan Ahamed

DOI: 10.1097/hep.0000000000001670

Cited by: 0

Fields of Study & Subjects

Liver Disease Diagnosis and Treatment Hepatitis C virus research Opioid Use Disorder Treatment